Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Supportive care in multiple myeloma.

Asher Chanan-Khan1, Kena C Miller

  • 1Roswell Park Cancer Institute, Buffalo, NY 14263, USA. asher.chanan-khan@roswellpark.org

Clinical Lymphoma & Myeloma
|August 2, 2006
PubMed
Summary

Recent advances in multiple myeloma treatment improve survival. Aggressive management of treatment complications is crucial for patient quality of life and treatment success, emphasizing supportive care.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Mayo Clinic Systematic Management and Risk-Adapted Therapy for Lymphoid Malignancies (lySMART) Consensus Guidelines 2026.

Mayo Clinic proceedings·2026
Same author

Number needed to treat to avoid progression and death and cost analysis: zanubrutinib versus acalabrutinib in relapsed/refractory chronic lymphocytic leukemia.

Future oncology (London, England)·2026
Same author

Multi-omics analysis reveals a unique epigenetic signature in <i>MYD88</i> wild-type Waldenström macroglobulinemia.

Haematologica·2025
Same author

Safety, tolerability, and pharmacokinetics of lisaftoclax (APG-2575)-based therapy in patients with chronic lymphocytic leukemia: Phase 1b/2 study.

Med (New York, N.Y.)·2025
Same author

Number needed to treat and associated cost analysis of zanubrutinib vs ibrutinib in chronic lymphocytic leukemia.

Journal of managed care & specialty pharmacy·2025
Same author

The clinical impact of acquired von Willebrand syndrome secondary to Waldenström macroglobulinemia: an underrecognized source of major bleeding events.

Leukemia·2024

Area of Science:

  • Hematology
  • Oncology
  • Internal Medicine

Background:

  • Multiple myeloma treatment has advanced significantly, improving disease control and survival rates.
  • New therapeutic agents and combinations are available for multiple myeloma management.
  • Disease- and therapy-associated complications require careful attention.

Purpose of the Study:

  • To review critical supportive care measures for optimal multiple myeloma patient management.
  • To highlight the importance of managing complications in multiple myeloma.

Main Methods:

  • Literature review of recent advancements in multiple myeloma treatment.
  • Analysis of supportive care strategies and complication management.
  • Synthesis of evidence on quality of life and treatment outcomes.

Main Results:

  • Improved disease control and survival trends observed with new treatments.
  • Supportive care significantly impacts patient quality of life.
  • Aggressive management of complications is integral to successful treatment outcomes.

Conclusions:

  • Optimal care for multiple myeloma necessitates a strong focus on supportive measures.
  • Proactive management of complications is key to enhancing patient outcomes and quality of life.
  • Continued emphasis on supportive care is vital alongside therapeutic advancements.

Related Experiment Videos